Two Sigma Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-98,360
| Closed | -$44.6M | – | 2116 |
|
|
2025
Q4 | $44.6M | Buy |
98,360
+86,860
| +755% | +$37.4M | 0.09% | 201 |
|
|
2025
Q3 | $4.5M | Buy |
11,500
+10,600
| +1,178% | +$4.43M | 0.01% | 785 |
|
|
2025
Q2 | $401K | Buy |
+900
| New | +$415K | ﹤0.01% | 1847 |
|
|
2025
Q1 | – | Sell |
-3,200
| Closed | -$1.29M | – | 2597 |
|
|
2024
Q4 | $1.29M | Sell |
3,200
-26,200
| -89% | -$12.1M | ﹤0.01% | 1342 |
|
|
2024
Q3 | $13.7M | Sell |
29,400
-142,400
| -83% | -$68.4M | 0.03% | 405 |
|
|
2024
Q2 | $80.5M | Buy |
171,800
+49,800
| +41% | +$21.6M | 0.18% | 115 |
|
|
2024
Q1 | $51M | Buy |
122,000
+34,500
| +39% | +$14.6M | 0.12% | 178 |
|
|
2023
Q4 | $35.6M | Sell |
87,500
-55,900
| -39% | -$20.7M | 0.08% | 234 |
|
|
2023
Q3 | $49.9M | Sell |
143,400
-71,000
| -33% | -$24.8M | 0.13% | 164 |
|
|
2023
Q2 | $75.4M | Buy |
214,400
+154,000
| +255% | +$51.9M | 0.19% | 126 |
|
|
2023
Q1 | $19M | Buy |
60,400
+42,600
| +239% | +$12.8M | 0.05% | 345 |
|
|
2022
Q4 | $5.14M | Sell |
17,800
-5,200
| -23% | -$1.58M | 0.01% | 772 |
|
|
2022
Q3 | $6.66M | Sell |
23,000
-1,700
| -7% | -$489K | 0.02% | 625 |
|
|
2022
Q2 | $6.96M | Buy |
24,700
+6,900
| +39% | +$1.85M | 0.02% | 632 |
|
|
2022
Q1 | $4.64M | Buy |
17,800
+5,500
| +45% | +$1.31M | 0.01% | 827 |
|
|
2021
Q4 | $2.7M | Sell |
12,300
-770,400
| -98% | -$150M | 0.01% | 1046 |
|
|
2021
Q3 | $142M | Buy |
782,700
+781,700
| +78,170% | +$153M | 0.37% | 64 |
|
|
2021
Q2 | $202K | Buy |
+1,000
| New | +$209K | ﹤0.01% | 2271 |
|
|
2021
Q1 | – | Sell |
-262,837
| Closed | -$62.1M | – | 2735 |
|
|
2020
Q4 | $62.1M | Sell |
262,837
-514,800
| -66% | -$118M | 0.17% | 131 |
|
|
2020
Q3 | $212M | Sell |
777,637
-438,275
| -36% | -$121M | 0.6% | 36 |
|
|
2020
Q2 | $353M | Buy |
1,215,912
+113,900
| +10% | +$30.9M | 1.04% | 14 |
|
|
2020
Q1 | $262M | Sell |
1,102,012
-102,700
| -9% | -$23.6M | 1% | 10 |
|
|
2019
Q4 | $264M | Buy |
1,204,712
+301,100
| +33% | +$60.9M | 0.61% | 34 |
|
|
2019
Q3 | $153M | Sell |
903,612
-32,100
| -3% | -$5.68M | 0.37% | 62 |
|
|
2019
Q2 | $172M | Sell |
935,712
-67,700
| -7% | -$11.8M | 0.43% | 48 |
|
|
2019
Q1 | $185M | Buy |
1,003,412
+258,400
| +35% | +$47.7M | 0.47% | 43 |
|
|
2018
Q4 | $123M | Buy |
745,012
+219,000
| +42% | +$37.9M | 0.34% | 72 |
|
|
2018
Q3 | $101M | Buy |
526,012
+192,600
| +58% | +$34.3M | 0.25% | 112 |
|
|
2018
Q2 | $56.7M | Sell |
333,412
-479,800
| -59% | -$74.4M | 0.15% | 170 |
|
|
2018
Q1 | $133M | Sell |
813,212
-414,200
| -34% | -$67.7M | 0.36% | 60 |
|
|
2017
Q4 | $184M | Buy |
1,227,412
+368,162
| +43% | +$54.5M | 0.5% | 32 |
|
|
2017
Q3 | $131M | Sell |
859,250
-3,351
| -0.4% | -$504K | 0.37% | 63 |
|
|
2017
Q2 | $111M | Sell |
862,601
-295,767
| -26% | -$35.6M | 0.37% | 60 |
|
|
2017
Q1 | $127M | Buy |
1,158,368
+63,539
| +6% | +$5.59M | 0.42% | 44 |
|
|
2016
Q4 | $80.7M | Buy |
1,094,829
+834,476
| +321% | +$67.9M | 0.31% | 80 |
|
|
2016
Q3 | $22.7M | Buy |
260,353
+28,067
| +12% | +$2.65M | 0.1% | 237 |
|
|
2016
Q2 | $20M | Sell |
232,286
-713,380
| -75% | -$61.6M | 0.1% | 230 |
|
|
2016
Q1 | $75.2M | Buy |
945,666
+672,976
| +247% | +$60.9M | 0.42% | 57 |
|
|
2015
Q4 | $34.3M | Sell |
272,690
-28,606
| -9% | -$3.45M | 0.2% | 136 |
|
|
2015
Q3 | $32M | Buy |
301,296
+287,800
| +2,132% | +$37M | 0.2% | 129 |
|
|
2015
Q2 | $1.67M | Buy |
+13,496
| New | +$1.7M | 0.01% | 888 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 2439 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 2841 |
|
Other funds holding VRTX
VCM
VPM
